Neochlorogenic Acid Combined with Bone Marrow Mesenchymal Stem Cells Encapsulated into GelMA Hydrogel for Transplantation to Repair Intervertebral Disk Degeneration

Biomacromolecules. 2024 Feb 12;25(2):729-740. doi: 10.1021/acs.biomac.3c00923. Epub 2024 Jan 23.

Abstract

Intervertebral disk degeneration is a common disease with an unknown etiology. Currently, tissue engineering is considered to be an important method for intervertebral disk repair. Although transplanted stem cells may disrupt the repair process because of apoptosis caused by the oxidative microenvironment. Herein, bone marrow mesenchymal stem cell (BMSC) and Neochlorogenic acid (Ncg) were encapsulated into a GelMA hydrogel as a carrier to protect transplanted stem cells. Ncg effectively inhibited the oxidative stress process and reduced the apoptosis rate. A 5% GelMA hydrogel had a large pore size and porosity that provided an enhanced survival space for cells. An in vivo assessment showed that treatment with GelMA + BMSC + Ncg produced greater repair of degenerated intervertebral disks than that found in other model groups. Thus, this study may help contribute to improving stem cell transplantation for treating intervertebral disk degeneration.

MeSH terms

  • Bone Marrow Cells
  • Chlorogenic Acid / analogs & derivatives*
  • Humans
  • Hydrogels / pharmacology
  • Intervertebral Disc Degeneration* / therapy
  • Intervertebral Disc*
  • Mesenchymal Stem Cell Transplantation* / methods
  • Mesenchymal Stem Cells*
  • Quinic Acid / analogs & derivatives*

Substances

  • Hydrogels
  • 5'-O-caffeoylquinic acid
  • Chlorogenic Acid
  • Quinic Acid